scholarly article | Q13442814 |
P50 | author | Marleen Boelaert | Q28817180 |
P2093 | author name string | J Robays | |
P Lutumba | |||
P Van der Stuyft | |||
P Lefèvre | |||
S Lubanza | |||
V Kande Betu Ku Mesu | |||
P2860 | cites work | The lessons of user fee experience in Africa | Q33580186 |
Trypanosomiasis control, Democratic Republic of Congo, 1993-2003 | Q35847379 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Democratic Republic of the Congo | Q974 |
P304 | page(s) | 290-298 | |
P577 | publication date | 2007-02-01 | |
P1433 | published in | Tropical Medicine and International Health | Q15765747 |
P1476 | title | Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo | |
P478 | volume | 12 |
Q33528943 | A CATT negative result after treatment for human African trypanosomiasis is no indication for cure |
Q35126629 | A mixed methods study of a health worker training intervention to increase syndromic referral for gambiense human African trypanosomiasis in South Sudan. |
Q26825682 | Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review |
Q33834052 | Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study |
Q34305891 | Early prediction of treatment efficacy in second-stage gambiense human African trypanosomiasis |
Q39401301 | Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola |
Q58842233 | Ethical Considerations for Global Health Decision-Making: Justice-Enhanced Cost-Effectiveness Analysis of New Technologies for |
Q35345427 | From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study |
Q39052722 | Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo |
Q29056943 | Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency? |
Q37034565 | Human African trypanosomiasis in Côte d'Ivoire and Burkina Faso: optimization of epidemiologic surveillance strategies |
Q37302722 | Human African trypanosomiasis in a rural community, Democratic Republic of Congo |
Q34500882 | Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review |
Q56888277 | Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda's human African trypanosomiasis elimination programme |
Q64296317 | Integration of Human African Trypanosomiasis Control Activities into Primary Health Services in the Democratic Republic of the Congo: A Qualitative Study of Stakeholder Perceptions |
Q57061698 | Knowledge, attitudes and practices about human African trypanosomiasis and their implications in designing intervention strategies for Yei county, South Sudan |
Q56504613 | Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis |
Q27004352 | Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests |
Q28555206 | Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo |
Q36198356 | Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan |
Q33745212 | Quantifying the burden of rhodesiense sleeping sickness in Urambo District, Tanzania |
Q28478935 | Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo |
Q38759672 | Social stigma towards neglected tropical diseases: a systematic review |
Q52602671 | The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis. |
Q47186581 | The socio-economic burden of human African trypanosomiasis and the coping strategies of households in the South Western Kenya foci |
Q36551049 | Treatment options for second-stage gambiense human African trypanosomiasis |
Search more.